Medical/Pharmaceuticals

POMDOCTOR LIMITED Announces Closing of Initial Public Offering

GUANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases inChina, today announced the closing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shar...

2025-10-10 04:05 1917

Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery

NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ -- Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with AstraZeneca to advance AI-powered drug discovery in immunology. The partnership will combine Algen...

2025-10-09 23:09 1126

LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect

BEIJING, Oct. 9, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease interventional solutions, recently announced that LuX-Valve Plus transjugular tricuspid valve replacemen...

2025-10-09 21:00 1284

Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission

* The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Application (NDA) submission * World-first regimen in gastric cancer that replaces adjuvant chemotherapy with mono-immunotherapy in the perioperati...

2025-10-09 20:50 1531

Field Medical First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025

Three sessions feature new outcomes, a live case, and preclinical research with the FieldForce™ Ablation System. CARDIFF-BY-THE-SEA, Calif., and PHILADELPHIA, Oct. 9, 2025 /PRNewswire/ --  Field Medical, Inc

2025-10-09 20:33 1078

Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™

* ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed * ExellenS TM combines the company's commitment to operational excellence with its core manufacturing competencies, guided by standardization, simplification, and scalab...

2025-10-09 19:00 1329

Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87

HANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that it has reached an exclusive commercialization agreement wit...

2025-10-09 17:27 1273

Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI

TAIPEI, Oct. 9, 2025 /PRNewswire/ -- Advantech (TWSE: 2395), a global leader in edge computing and AI solutions, is proud to announce the launch of the AOM-5721, a SMARC-based Arm Computer-on-Module powered by the Qualcomm® Dragonwing™ QCS6490 SoC. By combining Advantech's expertise in compact, ...

2025-10-09 17:05 1080

Herbalgy, the Pain Management Expert, Partners with Heroes in White to Champion a "Pain-Relieving Serenity" Lifestyle

Bringing the Wisdom of Traditional Chinese Medicine into Modern Living HONG KONG, Oct. 9, 2025 /PRNewswire/ -- Following the phenomenal success of TVB's widely acclaimed TV dramaHeroes in White—the top-rated series of 2025 with an audience of over 1.57 million and a rating of 24.2 points—Herbalgy...

2025-10-09 14:18 1103

Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology

* The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted acrossAsia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the large...

2025-10-09 13:10 1246

EDAN Expands U.S. Operations with New Manufacturing Hub

Facility marks EDAN's 30th anniversary and kickstarts global supply chain ecosystem SAN DIEGO, Oct. 8, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a global leader in medical device innovation, announced the official opening of its new U.S. manufactu...

2025-10-09 06:53 1022

Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

SEOUL, South Korea, Oct. 9, 2025 /PRNewswire/ -- The World Federation of Neurology (WFN) and the Korean Neurological Association (KNA) will host the XXVII World Congress of Neurology

2025-10-09 04:41 1071

C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025

BARCELONA, Spain, Oct. 8, 2025 /PRNewswire/ -- During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM 2025), C-Ray Therapeutics (Shanghai) Co., Ltd. ("C-Ray Shanghai"), a company dedicated to the development of innovative targeted radiopharmaceuticals, announced pro...

2025-10-08 22:20 1085

India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research

CHENNAI, India, Oct. 8, 2025 /PRNewswire/ -- India's No:1 Ranked Institute, the Indian Institute of Technology Madras , and Danish researchers have shown how interactions between genetic variants can act like 'switches' to unlock hidden cellular pathways.

2025-10-08 21:48 1188

NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street

NEW YORK, Oct. 8, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + The AW Playmaker Award...

2025-10-08 21:20 1873

Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System

〜Driving Technology Transfer and Test Manufacturing Following Regulatory Approval to Launch Company-Led af-001 Trial〜 TOKYO, Oct. 8, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Alpha Fusion) is proud to announce a joint initiative with the Kobe City Medical Center General Hospital (KCGH) to establis...

2025-10-08 21:00 1123

POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

GUANGZHOU, China, Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases inChina, today announced the pricing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at...

2025-10-08 20:00 1510

/C O R R E C T I O N -- World Meditation League (WML)/

In the news release, An Era Where Meditation Becomes a Quantifiable Achievement --Japan's First "Quantified Meditation Challenge", issued Oct. 7, 2025 by World Meditation League (WML) over PR Newswire, we are advised by the company that the photos have been updated. The complete, corrected releas...

2025-10-08 19:46 2500

Siemens Healthineers and National University Hospital Partner on Research to Advance Non-Invasive Liver Disease Diagnostics

* Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease * Advancing ultrasound technologies that are safer, more accessible alternatives to invasive diagnostic procedures * Research le...

2025-10-08 11:15 1425

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment

HMI-115 demonstrated statistically significant improvement in endometriosis pain The mean dysmenorrhea pain score was reduced by 42% The mean non-menstrual pelvic pain score was reduced by 52% Most of the patients had normal menstrual periods No typical peri-menopausal symptoms were reported Th...

2025-10-08 09:08 1778
1 ... 27282930313233 ... 644

Week's Top Stories